While a record-setting amount in the AD research world, this year’s $1.8 billion appropriation is a fraction of what other costly diseases receive. By comparison, the budget the National Cancer Institute $5.7 billion for its research programs.
“Compared to what the cost of the disease brings to Americans in terms of Medicare, Medicaid, and out of pocket expenses, it’s not that much,” Mr. Egge said. “But we have the opportunity to use this money to change these huge numbers that we’re facing.”
A 2013by the Rand Corporation found that, although Alzheimer’s affects fewer people than cancer or heart disease, the cost of treating and caring for those patients far outstrips spending in either of those other categories. The conclusions were perhaps even more startling, considering that it looked only at costs related solely to Alzheimer’s, not the cost of treating comorbid illnesses.